<DOC>
	<DOCNO>NCT02302352</DOCNO>
	<brief_summary>Systemic sclerosis ( SSc ) autoimmune disease unknown etiology , affect especially gastrointestinal tract , lung , heart kidney . Immunological abnormality characterize innate acquire immune disturbance associate disease development . The present study aim evaluate efficacy safety probiotic gastrointestinal symptom , nutritional status innate acquire immune response , mean evaluation IgA , Treg Th1 , Th2 , Th17 T helper subtypes level patient SSc . In addition level CD4+ T helper Th1 , Th2 Th17 subtypes Treg level compare healthy control group .</brief_summary>
	<brief_title>Effects Probiotics Gastrointestinal Symptoms Immune System Patients With Systemic Sclerosis</brief_title>
	<detailed_description>Systemic sclerosis ( SSc ) chronic autoimmune disease , affect gastrointestinal tract , lung , heart kidney . A shift balance T helper 1 ( Th1 ) Th2 subtypes regulatory T cell ( Treg ) Th17 cell level , well intestinal microbiota abnormality may present SSc . These abnormality stimulate inflammatory response , cause intestinal epithelial damage . The use oral probiotic microbiome immune response modulation attractive especially autoimmune disease . Objectives : To evaluate efficacy safety probiotic gastrointestinal symptom , nutritional status innate acquire immune response , mean evaluation IgA , Treg Th1 , Th2 , Th17 T helper subtypes level patient SSc . In addition level CD4+ T helper Th1 , Th2 Th17 subtypes Treg level compare healthy control group . Patients method : A randomized double-blind placebo-controlled clinical trial , 76 SSc patient perform . Patients randomly assign receive oral probiotic day placebo 8 week . The primary outcome change gastrointestinal symptom baseline week 8 . Clinical evaluation , scleroderma Health Assessment Questionnaire ( sHAQ ) , food intake record , anthropometry assessment laboratory evaluation perform baseline ( T0 ) , week 4 ( T1 ) week 8 ( T2 ) . C-reactive protein ( CRP ) immunoglobulin A ( IgA ) serum level assessment perform visit . The proportion CD4+ CD8+ T cell , Tregs ( CD4+CD25+Foxp3+CD127low ) , Th1 , Th2 e Th17 CD4+ T cell subset level evaluate use flow cytometer visit SSc patient also 50 healthy subjetcs .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Patients systemic sclerosis accord 2013 ACR/EULAR classification criterion SSc ; Patients gastrointestinal symptom relate SSc include : gastrointestinal reflux , bloating , diarrhea constipation ; Written inform consent provide subject . Overlap syndromes systemic lupus erythematosus , polymyositis/dermatomyositis rheumatoid arthritis ; Use antibiotic and/or probiotic four week baseline ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Immune system</keyword>
</DOC>